AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 149 filers reported holding AMICUS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $246,667 | -58.8% | 25,829 | -57.4% | 0.00% | -60.0% |
| Q1 2021 | $598,995 | -75.0% | 60,627 | -41.5% | 0.01% | -72.2% |
| Q4 2020 | $2,392,124 | +115.5% | 103,600 | +31.8% | 0.02% | +50.0% |
| Q3 2020 | $1,110,000 | +856.9% | 78,600 | +528.9% | 0.01% | +500.0% |
| Q1 2020 | $116,000 | -95.6% | 12,498 | -95.4% | 0.00% | -90.0% |
| Q4 2019 | $2,620,000 | -18.8% | 269,000 | +4.1% | 0.02% | -13.0% |
| Q2 2019 | $3,225,000 | +2021.7% | 258,381 | +1532.5% | 0.02% | +2200.0% |
| Q4 2018 | $152,000 | -35.0% | 15,827 | +5.5% | 0.00% | 0.0% |
| Q2 2018 | $234,000 | +20.6% | 15,005 | -22.3% | 0.00% | 0.0% |
| Q2 2017 | $194,000 | -23.6% | 19,300 | -45.7% | 0.00% | -50.0% |
| Q1 2017 | $254,000 | +128.8% | 35,539 | +136.9% | 0.00% | +100.0% |
| Q3 2016 | $111,000 | -41.3% | 15,000 | -32.9% | 0.00% | 0.0% |
| Q1 2016 | $189,000 | -68.2% | 22,358 | -77.6% | 0.00% | -75.0% |
| Q3 2014 | $595,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 22,790,134 | $182,777,000 | 6.12% |
| Perceptive Advisors | 24,609,700 | $197,369,000 | 5.32% |
| SECTORAL ASSET MANAGEMENT INC | 3,441,922 | $27,604,000 | 4.76% |
| Palo Alto Investors LP | 7,162,920 | $57,447,000 | 3.83% |
| Avoro Capital Advisors LLC | 11,100,000 | $89,022,000 | 3.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,930,320 | $23,501,000 | 3.63% |
| Ghost Tree Capital, LLC | 1,705,000 | $13,674,000 | 3.48% |
| Novo Holdings A/S | 2,317,870 | $18,589,000 | 3.18% |
| Copernicus Capital Management, LLC | 335,000 | $2,687,000 | 2.50% |
| Boxer Capital, LLC | 2,325,000 | $18,647,000 | 1.35% |